Arca Biopharma

ABIO

2.65

-0.05

-1.9%

Stock Price
Open: 2.75
Prev. Close: 2.70
Low/Hi: 2.65 - 2.75
52-Week: 2.15 - 4.22
Volumes
Equity: 18,642
90-Day Avg: 31,752
Volatility
Today: 65.6
20-Day: 71.9
52-Week: 66.3
Fundamental
Div. Yield: 0.0%
Earnings: 11-May (Est.)
P/E Ratio:
Market Cap: 24.8 M
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ABIO Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Dec-2016 30-Sep-2016 30-Jun-2016 31-Mar-2016
Cash and Cash Equivalents 7,401 8,095 14,379 29,717
Short Term Investments 13,762 15,373 11,979 910
Investments - - - -
Accounts Receivable 0 0 0 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 0 0 0 0
Net Property Plant and Equipment 66 69 76 24
Other Current Assets 282 320 377 391
Current Assets 21,445 23,788 26,735 31,018
Goodwill and Intangibles 0 0 0 0
Long Term Investments 2,352 3,967 5,008 5,306
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 24,629 28,679 32,635 36,928
Short Term Debt 0 0 0 0
Other Non-Current Assets 766 855 816 580
Accounts Payable 1,205 1,141 760 744
Accrued Liabilities and Other Payables 1,191 1,015 937 1,600
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 2,435 2,199 1,744 2,344
Other Current Liabilities 0 0 0 0
Accumulated Other Comprehensive Income -19 -6 13 6
Preferred Stock 0 0 0 0
Current Liabilities 2,396 2,156 1,697 2,344
Common Stock 9 9 9 9
Other Non-Current Liabilities 39 43 47 0
Additional Paid-In Capital 134,715 134,744 134,477 134,283
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -112,511 -108,267 -103,608 -99,714
Total Equity 22,194 26,480 30,891 34,584
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 7,401 38,802 15,354 16,756
Short Term Investments 13,762 0 0 0
Investments - - - -
Accounts Receivable 0 0 0 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 0 0 0 0
Net Property Plant and Equipment 66 28 36 29
Other Current Assets 282 114 134 169
Current Assets 21,445 38,916 15,488 16,925
Goodwill and Intangibles 0 0 0 0
Long Term Investments 2,352 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 24,629 39,574 16,132 17,084
Short Term Debt 0 0 0 0
Other Non-Current Assets 766 630 608 130
Accounts Payable 1,205 364 795 597
Accrued Liabilities and Other Payables 1,191 1,140 593 905
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 2,435 1,504 1,391 1,503
Other Current Liabilities 0 0 0 0
Accumulated Other Comprehensive Income -19 0 0 0
Preferred Stock 0 0 0 0
Current Liabilities 2,396 1,504 1,388 1,502
Common Stock 9 9 21 16
Other Non-Current Liabilities 39 0 3 1
Additional Paid-In Capital 134,715 134,128 99,342 90,498
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -112,511 -96,067 -84,622 -74,933
Total Equity 22,194 38,070 14,741 15,581